ghk cu holland and barrett GHK-Cu 50mg Copper Peptide Research-Grade NL-GHK-Cu™ (TETRAPEPTIDE + CU)

They have similar structures but slightly different lengths and functions

& Virshup, D

Untreated Controls Preclinical injury models % reduction in healing time Tendon Transection (Rat Achilles model)50% Skin Wound Closure (Alkali burn model)45% Muscle Crush Injury (Rat quadriceps)40% Safety Data Safety Profile from Research What preclinical and early clinical studies report Preclinical Safety Summary LD50Not achieved Acute toxicityNone observed Chronic toxicityNone in 6-month studies Organ toxicityNone detected Human IV pilot (n=2)No adverse effects Cardiac/hepatic/renalNo effects detected Regulatory & Risk Considerations FDA statusUnapproved drug WADA statusBanned since 2022 (S0) Human trialsPhase 1 only Long-term effectsUnknown in humans Pro-angiogenic riskTheoretical unstudied Australia/NZPrescription only No lethal dose was reached in preclinical toxicology studies

Possible side effects include mild irritation at the injection site, headaches, nausea, and others, depending on the specific peptide

, , , (), ( )

Glutathione works as a master antioxidant and instantly neutralizes various oxidants such as nitric oxide, peroxynitrite, lipid peroxides and superoxides etc